Oligon Therapeutics @ AIMed25 Conference: Session on AI IN RESEARCH AND PHARMA

San Diego, CA, Nov 10, 2025, AIMed25 Conference:

Oligon Therapeutics gave a keynote presentation and participated in a panel discussion at the AI IN RESEARCH AND PHARMA session.

‍

Conference: AIMed 2025

‍Sesion Title: AI in Research and Pharma

Oligon's Title: AI empowered RNA therapeutics

Abstract: Our RNA drug platform integrates dual oligo-binders (RNA aptamers) with dual oligo-silencers (siRNA) into a single self delivering SeekR drug. The dual oligo-binders are engineered to seek out and cross link two specific cell surface receptors, which  achieves unprecedented selectivity for delivery to the right cell subtypes, and triggers highly efficient cellular internalization. Innovations in AI based molecular modeling have transformed how our scientists discover and optimize RNA oligo-binder interactions with target cell surface receptor proteins to create the next generation of RNA therapeutics.

‍

Speaker Spyro Mousses PhD, CEO, Oligon Therapeutics

‍

‍

‍

‍